Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases.
Beuselinck B, Wolter P, Karadimou A, Elaidi R, Dumez H, Rogiers A, Van Cann T, Willems L, Body JJ, Berkers J, Van Poppel H, Lerut E, Debruyne P, Paridaens R, Schöffski P.
Beuselinck B, et al. Among authors: dumez h.
Br J Cancer. 2012 Nov 6;107(10):1665-71. doi: 10.1038/bjc.2012.385.
Br J Cancer. 2012.
PMID: 23132391
Free PMC article.